BIOMAT Database Logo BIOMAT Database Logo

[Inhibition of DNA synthesis in peripheral leukemic cells by cytosine-arabinoside; attempt at deriving therapeutic application]. 1981

A Schleusner, and M Schütt, and P Langen

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D007962 Leukocytes White blood cells. These include granular leukocytes (BASOPHILS; EOSINOPHILS; and NEUTROPHILS) as well as non-granular leukocytes (LYMPHOCYTES and MONOCYTES). Blood Cells, White,Blood Corpuscles, White,White Blood Cells,White Blood Corpuscles,Blood Cell, White,Blood Corpuscle, White,Corpuscle, White Blood,Corpuscles, White Blood,Leukocyte,White Blood Cell,White Blood Corpuscle
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002455 Cell Division The fission of a CELL. It includes CYTOKINESIS, when the CYTOPLASM of a cell is divided, and CELL NUCLEUS DIVISION. M Phase,Cell Division Phase,Cell Divisions,Division Phase, Cell,Division, Cell,Divisions, Cell,M Phases,Phase, Cell Division,Phase, M,Phases, M
D003561 Cytarabine A pyrimidine nucleoside analog that is used mainly in the treatment of leukemia, especially acute non-lymphoblastic leukemia. Cytarabine is an antimetabolite antineoplastic agent that inhibits the synthesis of DNA. Its actions are specific for the S phase of the cell cycle. It also has antiviral and immunosuppressant properties. (From Martindale, The Extra Pharmacopoeia, 30th ed, p472) Ara-C,Arabinofuranosylcytosine,Arabinosylcytosine,Cytosine Arabinoside,Aracytidine,Aracytine,Cytarabine Hydrochloride,Cytonal,Cytosar,Cytosar-U,beta-Ara C,Ara C,Arabinoside, Cytosine,Cytosar U,beta Ara C
D003864 Depression, Chemical The decrease in a measurable parameter of a PHYSIOLOGICAL PROCESS, including cellular, microbial, and plant; immunological, cardiovascular, respiratory, reproductive, urinary, digestive, neural, musculoskeletal, ocular, and skin physiological processes; or METABOLIC PROCESS, including enzymatic and other pharmacological processes, by a drug or other chemical. Chemical Depression,Chemical Depressions,Depressions, Chemical
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Schleusner, and M Schütt, and P Langen
Teratogenesis and inhibition of DNA synthesis induced in rat embryos by cytosine arabinoside.
February 1971, Teratology,
A Schleusner, and M Schütt, and P Langen
Aberrant double replication of segments of chromosomal DNA following DNA synthesis inhibition by cytosine arabinoside.
October 1979, Experimental cell research,
A Schleusner, and M Schütt, and P Langen
Intracellular cytosine arabinoside accumulation and cytosine arabinoside triphosphate formation in leukemic blast cells is inhibited by etoposide and teniposide.
June 1992, Leukemia,
A Schleusner, and M Schütt, and P Langen
Imbalanced DNA synthesis induced by cytosine arabinoside and fludarabine in human leukemia cells.
July 2001, Biochemical pharmacology,
A Schleusner, and M Schütt, and P Langen
Quantitation of resistance of leukemic cells to cytosine arabinoside from BrdUrd/DNA bivariate histograms.
January 1992, Cytometry,
A Schleusner, and M Schütt, and P Langen
Differential cell-cycle-dependent inhibition of DNA synthesis by hydroxyurea and cytosine arabinoside in cultured L5178Y mouse lymphoma cells.
January 1979, Archivum immunologiae et therapiae experimentalis,
A Schleusner, and M Schütt, and P Langen
Chemical synthesis of DNA oligomers containing cytosine arabinoside.
October 1988, Nucleic acids research,
A Schleusner, and M Schütt, and P Langen
Inhibition of glycoprotein and glycolipid synthesis in hamster embryo cells by cytosine arabinoside and hydroxyurea.
November 1974, Nature,
A Schleusner, and M Schütt, and P Langen
Quantitation of resistance to cytosine arabinoside by myeloid leukemic cells expressing bcl-2.
August 1996, European journal of haematology,
A Schleusner, and M Schütt, and P Langen
Protection of leukemic cells by deoxycytidine: in vitro measures of protection against cytosine arabinoside.
May 1998, Leukemia research,
Copied contents to your clipboard!